Literature DB >> 15228583

Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.

Mark D Berry1.   

Abstract

The presence of the so-called trace amines 2-phenylethylamine, m-tyramine, p-tyramine, m-octopamine, p-octopamine and tryptamine in the mammalian central nervous system has been known for several decades. Despite much initial interest, these amines have largely been thought of as little more than metabolic by-products. The recent description of a family of mammalian trace amine receptors has, however, seen a resurgence of interest in the physiological role of this class of compounds. Although the trace amines are well documented to cause amphetamine-like effects, such responses only occur at concentrations multiple orders of magnitude above normal physiological levels. As such, it seems unlikely that these responses reflect the true physiological role of the trace amines. In this article previous studies showing responses to physiologically relevant concentrations of trace amines are reviewed, along with those showing a reciprocal relationship between trace amine levels and fluctuations in basal monoaminergic tone. On the basis of these studies it is hypothesized that the trace amines function as endogenous neuromodulators of classical monoamine neurotransmitters. These effects are seen as an altered neuronal sensitivity to monoamine neurotransmitters, with no change in neuronal excitability in the absence of neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228583     DOI: 10.1111/j.1471-4159.2004.02501.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  97 in total

1.  Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Authors:  Gregory M Miller
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

Review 2.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

Review 3.  Receptors of mammalian trace amines.

Authors:  Anita H Lewin
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

Review 4.  Trace amine-associated receptors and their ligands.

Authors:  R Zucchi; G Chiellini; T S Scanlan; D K Grandy
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

Review 5.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 6.  Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism.

Authors:  G D'Andrea; S Cevoli; D Colavito; A Leon
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 7.  Molecular Genetic Strategies in the Study of Corticohippocampal Circuits.

Authors:  Christopher C Angelakos; Ted Abel
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-01       Impact factor: 10.005

8.  Rat brain-uptake index for phenylethylamine and various monomethylated derivatives.

Authors:  Aron D Mosnaim; Owen H Callaghan; Thomas Hudzik; Marion E Wolf
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

9.  Synthesis and characterization of tyramine-based hyaluronan hydrogels.

Authors:  Aniq Darr; Anthony Calabro
Journal:  J Mater Sci Mater Med       Date:  2008-07-31       Impact factor: 3.896

10.  Analgesic effects of β-phenylethylamine and various methylated derivatives in mice.

Authors:  Aron D Mosnaim; Thomas Hudzik; Marion E Wolf
Journal:  Neurochem Res       Date:  2014-06-26       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.